Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

NCT04189094 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
140
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang Cancer Hospital

Collaborators